Can a simple test improve how doctors treat heart and metabolic disease?
NCT ID NCT05192590
First seen Feb 28, 2026 · Last updated Apr 30, 2026 · Updated 11 times
Summary
This study looked at whether a new test (CDMT) helps primary care doctors make better decisions for patients with cardiometabolic syndrome (a group of conditions like heart disease and diabetes). 247 board-certified doctors participated, and researchers measured how well they diagnosed and treated patients, as well as the cost of care. The goal was to see if the test improves care quality and reduces costs.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOMETABOLIC SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
QURE Healthcare
San Francisco, California, 94109, United States
Conditions
Explore the condition pages connected to this study.